AMAM - Ambrx Biopharma American Depositary Shares - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Ambrx Biopharma American Depositary Shares's activity chart (see below) currently has 21 price targets and 19 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.58% with an average time for these price targets to be met of 80.08 days.

Most recent stock forecast was given by from BAIRD on 16-Jan-2024. First documented stock forecast 13-Jul-2021.

Best performing analysts who are covering AMAM - Ambrx Biopharma American Depositary Shares:

Louise Chen Joel Beatty Yuan Zhi Reni Benjamin Corinne Jenkins Brian Abrahams

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Apr-2022

$22

$-6 (-21.43%)

$22

Buy Since 31-Jul-2023

$32

$4 (14.29%)

$33

Show more analysts

Please expand the browser size to see the chart

What is AMAM (Ambrx Biopharma American Depositary Shares) average time for price targets to be met?

On average it took 80.08 days on average for the stock forecasts to be realized with a an average price target met ratio 69.58

Which analyst has the current highest performing score on AMAM (Ambrx Biopharma American Depositary Shares) with a proven track record?

LOUISE CHEN

Which analyst has the most public recommendations on AMAM (Ambrx Biopharma American Depositary Shares)?

Louise Chen works at SCOTIABANK and has 8 price targets and 12 ratings on AMAM

Which analyst is the currently most bullish on AMAM (Ambrx Biopharma American Depositary Shares)?

Graig Suvannavejh with highest potential upside - $25

Which analyst is the currently most reserved on AMAM (Ambrx Biopharma American Depositary Shares)?

Corinne Jenkins with lowest potential downside - -$19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?